Aviva stock price forecast: Seller momentum likely to persist as AV slides toward $615
Aviva plc (AV) is trading at $620.60 after posting a daily decline of 4.29%. The price remains below its SMA-20 ($647.82), SMA-50 ($648.61), and SMA-200 ($652.09), signaling persistent short-, medium-, and long-term seller pressure.
Highlights
- Aviva executed a £4 million pension buyout for the Hille Ergonom scheme, securing benefits and allocating surplus assets for 74 members.
- The company advanced its generative AI initiatives by expanding AI-powered underwriting for individual critical illness, amid ongoing investor knowledge gaps and insider share purchases.
- Aviva trades below key moving averages with weak momentum and high volatility, with price likely to remain in the £615.00–£635.00 range and a low probability of near-term gains.
Broader selling pressure persists despite insider buying and AI initiatives
An insider transaction took place on March 16, as Aviva's Pippa Lambert acquired 229 shares at an average cost of GBX 634 per share. The Hille Ergonom Pension Scheme completed a £4 million buyout with Aviva to secure benefits for 74 members, with surplus assets allocated. Aviva also expanded its AI-powered underwriting summarisation tool to support individual critical illness applications within its generative AI initiatives, and recent company research highlighted knowledge gaps among UK investors, though price action has remained under broader selling pressure.
Diverging indicators as resistance holds and volatility intensifies intraday
The current price of Aviva ($620.60) remains below the SMA-20 ($647.82), SMA-50 ($648.61), and SMA-200 ($652.09), indicating short-, medium-, and long-term pressure from sellers. The Ichimoku Kijun sits at $648.20 and now acts as immediate resistance. Momentum readings are weak as the D1 MACD signals a strong sell and ADX remains soft at 13.05, pointing to a lack of directional strength. D1 RSI sits in neutral territory (51.89) but flashes a buy, while Stoch RSI and CCI are mostly neutral or oversold across intraday timeframes. BBP on D1 has moved to overbought territory but turns oversold on shorter horizons, highlighting sharp swings and increasing seller dominance intraday. The AO is neutral and does not confirm the downtrend. The price opened today at $639.06 after a small gap below the previous close ($648.40) and is currently trading near the session low ($617.17–$640.80). Today’s drop of 4.29% signals high volatility, with persistent pressure since the open and a decisively negative intraday tone. Notably, there are divergences among oscillators and momentum indicators, as the D1 RSI remains buoyant despite overall downward momentum.
Limited rebound odds as mixed signals reinforce downside risk
Looking ahead, the expected price range for the next 5 trading days is $615.00–$635.00. The probability of a price increase is very low (less than 20%), making further declines the more likely scenario for now. The baseline assumption is for the price to move sideways within this volatility band relative to current levels, as daily and weekly indicators display mixed signals. A bullish scenario would require a break above $648.20 (Ichimoku resistance), while a bearish move below $615.00 could open the way for further losses, with weekly moving averages still indicating underlying support below $620.
Earlier, analysts noted that Aviva was experiencing persistent bearish momentum and weak technical signals, with downside pressure dominating across multiple timeframes. The latest action reinforces this outlook as heightened volatility and deepening intraday losses keep the focus squarely on risks below $615.00, making further downside a distinct possibility in the near term.
Latest Aviva News
- Forex
- Crypto